Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
On July 24, 2025, Cognizant's trading volume reached $345 million, marking a 78.03% increase from the previous day, placing it at the 330th position in the day's stock market rankings. Cognizant's stock price fell by 0.60%.
Cognizant's AI Lab has made significant strides in artificial intelligence, securing two new U.S. patents in 2025. These patents bring the lab's total to 59 issued patents, with an additional 23 pending. The patents cover innovations in multi-objective coevolution of deep neural network architectures and optimizing loss functions through Taylor Series Expansion. These advancements address fundamental challenges in AI, focusing on improving model performance while maintaining resource efficiency.
The company has also open-sourced its Neuro AI Multi-Agent Accelerator platform, demonstrating a strategic approach that combines proprietary technology with open-source contributions. This dual strategy aims to accelerate market penetration while maintaining competitive advantages through core innovations. Cognizant's RHEA (Realizing Human Expertise through AI) technology received a Gold Award at GECCO 2025, highlighting its ability to integrate human expert knowledge into AI solutions, particularly in high-stakes scenarios like pandemic response strategies.
Cognizant's investment in foundational AI research, especially in evolutionary computing, positions the company uniquely in the corporate AI landscape. The expansion of their San Francisco research facility in 2024 further underscores their commitment to long-term AI capability development. The involvement of academic researchers, including a professor from UT Austin, indicates strong academic connections, which are crucial for accessing cutting-edge research talent and ideas in AI development.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios